Foghorn Therapeutics (FHTX) 2025 Conference Transcript

Foghorn Therapeutics (FHTX) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Good afternoon, everyone. Thank you for attending Jefferies Global Healthcare Conference. My name is Kelly Xu, one of the senior analysts on biotech team. And for this first set of chat session, we are very pleased to have mister Andrew Gostrok, Chief Executive Officer from Falkhawn Therapeutics. Welcome. Speaker1 Thank you. Speaker0 Maybe first we could recap the potential in addressing the chromatin regulatory system and the BA ...